press release

Aldevron to Build 14-Acre Gene Therapy Manufacturing Campus

August ground breaking of second GMP manufacturing facility Expands GMP and GMP SourceTM plasmid capacity 10-fold Supports gene editing, gene therapy, and cell therapy applications Includes synthetic production of nucleic acids, vertical integration for clients FARGO, N.D. (June 3, 2019) – Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies; announced […]

New Headache Care Program Connects Patients to Latest, Advanced Headache Treatments

MINNEAPOLIS, Minn. – More than four million people in the United States suffer from chronic migraines, experiencing at least 15 migraine days per month. 44 percent of people experiencing severe headaches or migraines are never diagnosed. University of Minnesota Health has launched a new Headache Care program to help Minnesotans gain quick access to specialized […]

Medical Alley Association Lauds State’s Investment in Health Technology and Innovation

Minneapolis, MN – On Tuesday, May 28, 2019, Medical Alley Association released the following statement in response to the newly-proposed state budget for FY 2020-2021: “With so much at stake, Medical Alley Association sincerely thanks Governor Tim Walz, Representative Melissa Hortman, Senator Paul Gazelka and all of the legislators who helped support provisions of the […]

Take the Pledge and Experience One Day Without Sound on May 31st

May 24, 2019 — Each of us is surrounded by a myriad of sounds that brings to life many of the things we hold dear. A child’s laugh. Our favorite song. A bird chirping. We might take these for granted, but 48 million Americans are experiencing some degree of hearing loss that partially or fully […]

Sandstone Diagnostics Raises Additional Series A Financing to Accelerate Zero Delay™ Plasma Technology Development

New Product Line Expands Company’s CentriFluidic™ Product Portfolio ZD is poised to dramatically improve both the patient blood collection process as well as the performance of clinical laboratory tests. Karen Drexler, CEO, Sandstone PLEASANTON, CA, USA, May 6, 2019 /EINPresswire.com/ — Sandstone Diagnostics, a medical device company committed to making high quality clinical testing ubiquitous, is […]

Carrie Meyer, Au.D. Joins Amplifon Hearing Health Care as Director of Clinical Programs

Minnesota-based hearing health care company established new position to lead quality initiatives and manage clinical oversight MINNEAPOLIS – May 6, 2019 – Amplifon Hearing Health Care, the leading independent provider of hearing benefit solutions in the U.S., has named Carrie Meyer, Au.D., to the newly established position of Director of Clinical Programs. Dr. Meyer brings more […]

New Study Utilizing Miromesh® Biologic Matrix Reports Excellent Patient Outcomes with No Reinterventions

New Study Reports Excellent Patient Outcomes with No Reinterventions at Two Years in Patients Who Underwent Laparoscopic Paraesophageal Hernia Repair Utilizing MIROMESH® Biologic Matrix A new study published in The American Journal of Surgery demonstrates improved long-term patient outcomes, with no reinterventions, and a 10% two-year radiographic recurrent rate when MIROMESH® Biologic Matrix was utilized […]

Medical Alley Association Backs Protect Medical Innovation Act

Minneapolis, MN – On Wednesday, April 10 2019, the United States House of Representatives introduced the Protect Medical Innovation Act to permanently repeal the harmful medical device excise tax. Medical Alley Association thanks the bill’s authors, as well as its hundreds of bipartisan cosponsors, including Minnesota Representatives Jim Hagedorn (R), Angie Craig (D), Dean Phillips […]

SilkTech Biopharmaceuticals’ IND Submission Cleared by FDA; Phase 2 Clinical Trial Initiated for Patients with Dry Eye Disease

Milestone Results in $6.2 Million in Additional VC Funding Minneapolis, MN – April 16, 2019 – PRWeb – SilkTech Biopharmaceuticals, a company devoted to improving eye health through the development of silk-derived protein biotherapeutics for the targeted treatment of Dry Eye Disease (DED), today announced the company has received clearance of its Investigational New Drug […]

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture

One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS, […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER